Back
Innate Pharma SA Stock Price Chart
Sponsored
IPHA
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
46
IPHA
Innate Pharma SA
Last Price:
$2.05
Seasonality Move:
0.12%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
The current trend is moderately bullish and IPHA is experiencing slight buying pressure.
Innate Pharma SA Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.26 | Sell |
20-day SMA: | 1.84 | Buy |
50-day SMA: | 1.82 | Buy |
200-day SMA: | 2.22 | Sell |
8-day EMA: | 2.08 | Sell |
20-day EMA: | 1.95 | Buy |
50-day EMA: | 1.9 | Buy |
200-day EMA: | 2.17 | Sell |
Innate Pharma SA Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 53.33 | Buy |
Chaikin Money Flow: | 4145 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.41 - 2.17) | Buy |
Bollinger Bands (100): | (1.73 - 2.31) | Buy |
Innate Pharma SA Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 2.06 while IPHA 8-day simple moving average is 2.26, which is a Sell signal.
-
The stock price of IPHA is 2.06 while Innate Pharma SA 20-day SMA is 1.84, which makes it a Buy.
-
Innate Pharma SA 50-day simple moving average is 1.82 while IPHA share price is 2.06, making it a Buy technically.
-
IPHA stock price is 2.06 and Innate Pharma SA 200-day simple moving average is 2.22, creating a Sell signal.
IPHA Technical Analysis vs Fundamental Analysis
Sell
46
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a SellThe current Innate Pharma SA [IPHA] share price is $2.06. The Score for IPHA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Innate Pharma SA Stock Info
Market Cap:
166.8M
Price in USD:
2.06
Share Volume:
24.1K
Innate Pharma SA 52-Week Range
52-Week High:
3.51
52-Week Low:
1.29
Sell
46
Innate Pharma SA (IPHA)
is a Sell
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?The Innate Pharma SA stock price is 2.06 USD today.
-
Will IPHA stock go up or go down?Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators
-
Is Innate Pharma SA overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is overvalued.
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 2.06 while IPHA 8-day exponential moving average is 2.08, which is a Sell signal.
-
The stock price of IPHA is 2.06 while Innate Pharma SA 20-day EMA is 1.95, which makes it a Buy.
-
Innate Pharma SA 50-day exponential moving average is 1.90 while IPHA share price is 2.06, making it a Buy technically.
-
IPHA stock price is 2.06 and Innate Pharma SA 200-day simple moving average is 2.17, creating a Sell signal.
Fundamental Analysis of Innate Pharma SA
Is Innate Pharma SA a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
-
IPHA Moving Average Covergence Divergence (MACD) indicator is 0.12, suggesting Innate Pharma SA is a Buy
-
Innate Pharma SA Relative Strength Index (RSI) is 53.33, which suggest Innate Pharma SA is overbought
-
The Bollinger Bands (25) for Innate Pharma SA is (1.41 - 2.17), which suggest Innate Pharma SA is a Buy
-
The Bollinger Bands (100) for Innate Pharma SA is (1.73 - 2.31), which suggest Innate Pharma SA is a Buy
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.